Providing integrated drug treatment services and criminal justice supervisionLearn More
To reduce drug trafficking and misuse by improving interagency collaboration, promoting accurate and timely information and intelligence sharing, and providing specialized training and other resources to its law enforcement, intelligence, treatment, and prevention initiatives.
News & Updates
The Drug Enforcement Administration (DEA) Washington Division has alerted Washington, D.C.-area residents of an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid, fentanyl. These pills, often purchased online or through social media websites, pose a serious public health and safety hazard. In an urgent video message posted on the DEA’s Twitter page today,... Read More
Meet the Washington/Baltimore HIDTA’s Executive Board Chairman, DEA Special Agent in Charge Jarod Forget
New W/B HIDTA Executive Board Chairperson, DEA SAC Jarod Forget, Describes His Vision & Leadership… Read More
As part of the national Overdose Response Strategy (ORS), the Virginia ORS team of the… Read More
On May 26, 2021, leaders from the United States Drug Enforcement Administration (DEA), the United… Read More
Who We Are
Covering 26 Counties and 11 Cities
In 1994, the Office of National Drug Control Policy (ONDCP) designated 13 jurisdictions in Maryland, the District of Columbia, and Northern Virginia as a HIDTA region. Since then, the Washington/Baltimore (W/B) HIDTA’s boundaries have expanded to include 26 counties and 11 cities in Maryland, Virginia, West Virginia, and the District of Columbia.
Want to learn more about our programs, and get the latest news and updates delivered to your mailbox? Never miss a story! Sign up here to get our monthly e-newsletter, The W/B HIDTA Monthly Journal.